Avrupa Birliği - İngilizce - EMA (European Medicines Agency)

vertex pharmaceuticals (ireland) limited - ivacaftor, tezacaftor, elexacaftor - cystic fibrosis - other respiratory system products - kaftrio is indicated in a combination regimen with ivacaftor for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Kanada - İngilizce - Health Canada

vertex pharmaceuticals (canada) incorporated - tezacaftor; ivacaftor; ivacaftor; elexacaftor - tablet - 50mg; 75mg; 150mg; 100mg - tezacaftor 50mg; ivacaftor 75mg; ivacaftor 150mg; elexacaftor 100mg - cystic fibrosis transmembrane conductance regulator correctors

Kanada - İngilizce - Health Canada

vertex pharmaceuticals (canada) incorporated - ivacaftor - granules - 25mg - ivacaftor 25mg - cystic fibrosis transmembrane conductance regulator potentiators

Kanada - İngilizce - Health Canada

vertex pharmaceuticals (canada) incorporated - tezacaftor; ivacaftor; ivacaftor; elexacaftor - tablet - 25mg; 37.5mg; 75mg; 50mg - tezacaftor 25mg; ivacaftor 37.5mg; ivacaftor 75mg; elexacaftor 50mg

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - tezacaftor, quantity: 50 mg; ivacaftor, quantity: 75 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; hypromellose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; hyprolose; purified talc - symdeko is indicated for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.,refer to table 1 for a list of responsive mutations.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 150 mg - tablet, film coated - excipient ingredients: silicon dioxide; sodium lauryl sulfate; hypromellose acetate succinate; magnesium stearate; croscarmellose sodium; carnauba wax; microcrystalline cellulose; lactose monohydrate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - trikafta 100/50/75 is indicated for the treatment of cystic fibrosis (cf) in patients aged 6 years and older who have at least one f508del mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene.

Avustralya - İngilizce - Department of Health (Therapeutic Goods Administration)

vertex pharmaceuticals australia pty ltd - tezacaftor, quantity: 100 mg; ivacaftor, quantity: 150 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; hypromellose; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; titanium dioxide; hyprolose; purified talc; iron oxide yellow - symdeko is indicated for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who have at least one mutation in the cystic fibrosis transmembrane conductance regulator (cftr) gene that is responsive to tezacaftor/ivacaftor based on in vitro data and/or clinical evidence.,refer to table 1 for a list of responsive mutations.

ABD - İngilizce - NLM (National Library of Medicine)

guangzhou jianyuan biological technology.co.,ltd - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - use to regrow hair on the top of the scalp (vertex only) remixidil foam is for some people who have a general thinning of hair on the top of the scalp (vertex only, as shownbelow). not intended for frontal baldness or a receding hairline. remixidil foam has been shown to regrow hair in some people with the following degrees of thinning hair or hair loss. stop use and ask a doctor if chest pain, rapid heartbeat, faintness, or dizziness occurs sudden unexplained weight gain occurs your hands or feet swell scalp irritation or redness occursunwanted facial hair growth occurs you do not see hair regrowth in 4 months ask a doctor before use if you have heart disease

ABD - İngilizce - NLM (National Library of Medicine)

guangzhou jianyuan biological technology.co.,ltd - minoxidil (unii: 5965120sh1) (minoxidil - unii:5965120sh1) - to regrow hair on the top of the scalp （vertex only） for hair loss and strengthening new hair growth do not use if your amount of hair loss is different than that shown on the side of this carton or your hair loss is on the front of the scalp. hair growth serum is not intended for frontal baldness or receding hairline.you have no family history of hair loss your hair loss is sudden and/or patchy you do not know the reason for your hair loss you are under 18 years of age. do not use on babies and children.your scalp is red, inflamed, infected, irritated , or painful you use other medicines on the scalp stop use and ask a doctor if chest pain, rapid heartbeat, faintness, or dizziness occurs sudden, unexplained weight gain occurs your hands or feet swell scalp irritation or redness occurs unwanted facial hair growth occurs you do not see hair regrowth in 4 months

Kanada - İngilizce - Health Canada

vertex pharmaceuticals (canada) incorporated - lumacaftor; ivacaftor - granules - 75mg; 94mg - lumacaftor 75mg; ivacaftor 94mg